Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8801 - 8808 of 12092 results
The Affordable Care Act’s Reporting Requirements for Carriers and Employers (Part 24 of 24): 5 Predictions
January 4, 2016| Blog| Viewpoint
Massachusetts Court: Patients Have Standing to Sue for Data Breach Based on Data Exposure Alone
January 4, 2016| Blog| Viewpoint
Happy New Year - Cybersecurity Information Sharing Act
January 4, 2016| Blog| Viewpoint
Delay in Implementing Cadillac Tax Raises Questions on Health Insurance
January 4, 2016| News
Health Care Cases to Watch in 2017
January 2, 2016| News
The Evolution of Patent Ineligible Subject Matter and the Federal Circuit
January 1, 2016| News
A Return to Evanston: FTC Revisits Old Ground in Yet Another Hospital Merger Challenge
January 1, 2016| News
Revel: To Stay or Not to Stay? Third Circuit Reveals the Answer
January 1, 2016| News
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|